Search Results

There are 16857 results for: content related to: Efficacy and safety of lorcaserin in obese adults: a meta-analysis of 1-year randomized controlled trials ( RCTs ) and narrative review on short-term RCTs

  1. You have full text access to this OnlineOpen article
    Effects of lorcaserin on pre-existing valvulopathy: A pooled analysis of phase 3 trials

    Obesity

    Neil J. Weissman, Steven R. Smith, Randi Fain, Nancy Hall and William R. Shanahan

    Version of Record online : 26 NOV 2016, DOI: 10.1002/oby.21695

  2. You have free access to this content
    Challenging obesity: Patient, provider, and expert perspectives on the roles of available and emerging nonsurgical therapies

    Obesity

    Volume 23, Issue S2, July 2015, Pages: S1–S26, Caroline M. Apovian, W. Timothy Garvey and Donna H. Ryan

    Version of Record online : 7 JUL 2015, DOI: 10.1002/oby.21140

  3. You have full text access to this OnlineOpen article
    Early weight loss while on lorcaserin, diet and exercise as a predictor of week 52 weight-loss outcomes

    Obesity

    Volume 22, Issue 10, October 2014, Pages: 2137–2146, Steven R. Smith, Patrick M. O'Neil, Arne Astrup, Nicholas Finer, Matilde Sanchez-Kam, Kyle Fraher, Randi Fain and William R. Shanahan

    Version of Record online : 18 JUL 2014, DOI: 10.1002/oby.20841

  4. You have free access to this content
    Randomized Placebo-Controlled Clinical Trial of Lorcaserin for Weight Loss in Type 2 Diabetes Mellitus: The BLOOM-DM Study

    Obesity

    Volume 20, Issue 7, July 2012, Pages: 1426–1436, Patrick M. O'Neil, Steven R. Smith, Neil J. Weissman, Meredith C. Fidler, Matilde Sanchez, Jinkun Zhang, Brian Raether, Christen M. Anderson and William R. Shanahan

    Version of Record online : 6 SEP 2012, DOI: 10.1038/oby.2012.66

  5. You have free access to this content
    Obesity consults—comprehensive obesity management in 2013: Understanding the shifting paradigm

    Obesity

    Volume 21, Issue S2, November 2013, Pages: S1–S15, Robert F. Kushner, Caroline M. Apovian and Ken Fujioka

    Version of Record online : 20 NOV 2013, DOI: 10.1002/oby.20627

  6. Safety and tolerability review of lorcaserin in clinical trials

    Clinical Obesity

    Volume 6, Issue 5, October 2016, Pages: 285–295, F. L. Greenway, W. Shanahan, R. Fain, T. Ma and D. Rubino

    Version of Record online : 14 SEP 2016, DOI: 10.1111/cob.12159

  7. Characterization of the discriminative stimulus effects of lorcaserin in rats

    Journal of the Experimental Analysis of Behavior

    Volume 106, Issue 2, September 2016, Pages: 107–116, Katherine M. Serafine, Kenner C. Rice and Charles P. France

    Version of Record online : 18 SEP 2016, DOI: 10.1002/jeab.222

  8. You have free access to this content
    Lorcaserin (APD356), a Selective 5-HT2C Agonist, Reduces Body Weight in Obese Men and Women

    Obesity

    Volume 17, Issue 3, March 2009, Pages: 494–503, Steven R. Smith, Warren A. Prosser, David J. Donahue, Michael E. Morgan, Christen M. Anderson, William R. Shanahan and APD356-004 Study Group

    Version of Record online : 6 SEP 2012, DOI: 10.1038/oby.2008.537

  9. Evaluation of the Abuse Potential of Lorcaserin, a Serotonin 2C (5-HT2C) Receptor Agonist, in Recreational Polydrug Users

    Clinical Pharmacology & Therapeutics

    Volume 89, Issue 5, May 2011, Pages: 683–692, MJ Shram, KA Schoedel, C Bartlett, RL Shazer, CM Anderson and EM Sellers

    Version of Record online : 16 MAR 2011, DOI: 10.1038/clpt.2011.20

  10. Exhumations: The Search for the Dead and the Resurgence of the Uncanny in Contemporary Spain

    Anthropology and Humanism

    Volume 38, Issue 1, June 2013, Pages: 36–53, Jennifer Sime

    Version of Record online : 14 JUN 2013, DOI: 10.1111/anhu.12001

  11. Effects of lorcaserin on fat and lean mass loss in obese and overweight patients without and with type 2 diabetes mellitus: the BLOSSOM and BLOOM-DM studies

    Diabetes, Obesity and Metabolism

    Volume 18, Issue 9, September 2016, Pages: 945–948, C. Apovian, K. Palmer, R. Fain, C. Perdomo and D. Rubino

    Version of Record online : 22 JUN 2016, DOI: 10.1111/dom.12690

  12. You have free access to this content
    Efficacy comparison of medications approved for chronic weight management

    Obesity

    Volume 23, Issue S1, April 2015, Pages: S4–S7, Rekha B. Kumar and Louis J. Aronne

    Version of Record online : 21 APR 2015, DOI: 10.1002/oby.21093

  13. You have free access to this content
    The Alhama de Murcia fault (SE Spain), a seismogenic fault in a diffuse plate boundary: Seismotectonic implications for the Ibero-Magrebian region

    Journal of Geophysical Research: Solid Earth (1978–2012)

    Volume 109, Issue B1, January 2004, E. Masana, J. J. Martínez-Díaz, J. L. Hernández-Enrile and P. Santanach

    Version of Record online : 2 JAN 2004, DOI: 10.1029/2002JB002359

  14. You have free access to this content
    Pharmacotherapy for weight loss: the cardiovascular effects of the old and new agents

    Journal of Clinical Pharmacy and Therapeutics

    Volume 39, Issue 5, October 2014, Pages: 475–484, C. P. Walter, B. E. Bleske and M. P. Dorsch

    Version of Record online : 13 JUN 2014, DOI: 10.1111/jcpt.12177

  15. You have full text access to this OnlineOpen article
    Characterization of the 5-HT2C receptor agonist lorcaserin on efficacy and safety measures in a rat model of diet-induced obesity

    Pharmacology Research & Perspectives

    Volume 3, Issue 1, February 2015, Guy A. Higgins, Jill Desnoyer, Annalise Van Niekerk, Leo B. Silenieks, Winnie Lau, Sandy Thevarkunnel, Julia Izhakova, Ines A.M. DeLannoy, Paul J. Fletcher, Josepha DeLay and Howard Dobson

    Version of Record online : 7 NOV 2014, DOI: 10.1002/prp2.84

  16. Lorcaserin

    Practical Diabetes

    Volume 30, Issue 3, 0/30 April 2013, Pages: 136–137, James Mclaren, Gerry McKay and Miles Fisher

    Version of Record online : 3 APR 2013, DOI: 10.1002/pdi.1760

  17. Functional foods as potential therapeutic options for metabolic syndrome

    Obesity Reviews

    Volume 16, Issue 11, November 2015, Pages: 914–941, L. Brown, H. Poudyal and S. K. Panchal

    Version of Record online : 8 SEP 2015, DOI: 10.1111/obr.12313

  18. The effect of antiobesity drugs on waist circumference: a mixed treatment comparison

    Diabetes, Obesity and Metabolism

    Volume 16, Issue 3, March 2014, Pages: 237–247, M. Chilton, A. Dunkley, P. Carter, M. J. Davies, K. Khunti and L. J. Gray

    Version of Record online : 15 SEP 2013, DOI: 10.1111/dom.12198

  19. You have full text access to this OnlineOpen article
    Current and emerging medications for overweight or obesity in people with comorbidities

    Diabetes, Obesity and Metabolism

    Volume 17, Issue 11, November 2015, Pages: 1021–1032, K. Fujioka

    Version of Record online : 8 JUL 2015, DOI: 10.1111/dom.12502

  20. Long-term effects of weight-reducing drugs in people with hypertension

    Intervention Review

    The Cochrane Library

    Andrea Siebenhofer, Klaus Jeitler, Karl Horvath, Andrea Berghold, Nicole Posch, Jutta Meschik and Thomas Semlitsch

    Published Online : 2 MAR 2016, DOI: 10.1002/14651858.CD007654.pub4